Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Regenerx Biopharm In
RGRXCurrent price
0.0014 USD
0 USD (0.00%)
Last closed
0.0014 USD
Company
www.regenerx.com
ISIN
US75886X1081
Sector
Healthcare
Industry
Biotechnology
Exchange
OTCQB
Capitalization
2 095 USD
Yield for 12 month
+180.00 %
1Y
3Y
5Y
10Y
15Y
RGRX
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for the treatment of dermal wounds and reduction of scar tissue. It has strategic partnerships with Lee's Pharmaceutical Group and HLB Therapeutics. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland. Address: 15245 Shady Grove Road, Rockville, MD, United States, 20850
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.5 USDP/E ratio
–Dividend Yield
–Current Year
+76 761 USD
Last Year
+76 761 USD
Current Quarter
+19 190 USD
Last Quarter
+19 190 USD
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures RGRX
1 year
3 years
5 years
10 years
EBITDA
-1 293 125 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-148.5 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
1.5 USD
Revenue TTM
76 760 USD
Book Value
-2.61 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
70 123 USD
Earnings per share
-0.97 USD
Diluted Eps TTM
-0.97 USD
Most Recent Quarter
I 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics RGRX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History RGRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:100
Payout Ratio
–
Last Split Date
18.10.2023
Dividend Date
–
Stock Valuation RGRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
18.1744
Price Sales TTM
0.0273
Enterprise Value EBITDA
-11.6119
Price Book MRQ
–
Financials RGRX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators RGRX
For 52 weeks
0.0002 USD
0.062 USD
50 Day MA
0.0099 USD
Shares Short Prior Month
293
200 Day MA
0.006 USD
Short Ratio
0.16
Shares Short
191
Short Percent
0.05 %
BeatStart